Important Message Regarding ELD Certification
Date: February 02, 2024
February 2, 2024
Dear ASRM Member,
In response to the predicted shortage of lab directors and embryologists, SRBT leadership had begun conversations with the American Board of Bioanalysis to explore reinstating the ELD certification. We regret that this process has not been as transparent and inclusive as it should have been and has clearly caused polarized discussions among our SRBT members. Based on the number of comments from our members, we realize that this request was clearly premature and may not be representative of the broad SRBT membership. Therefore, we are withdrawing this request to reinstate the ELD at this time.
In response, we are planning the following steps:
- We will conduct a survey of SART-affiliated laboratories to evaluate the current status and future needs of lab directors.
- A survey will be circulated to SRBT members seeking their viewpoints on the ELD certification, including potential new criteria.
- SRBT will be hosting a series of town hall meetings to present these findings and to listen to our members’ perspectives on addressing workforce challenges.
We are pleased about your passion and commitment to shaping the future of embryology and embryology lab leadership. Your feedback has been invaluable, and we are committed to ongoing engagement with you. We look forward to collaborating closely to develop effective and meaningful solutions.
Marina Gvakharia, MD, PhD
Paula Amato, MD
Steven D. Spandorfer, MD